Journal profile · Medicine-Oncology
Cancer Reports
ISSN 2573-8348 · Wiley · United States · Monthly · Founded 2018
Cancer Reports: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.5 (journal website); fully open access; APC about USD 3,440; median 226 days to acceptance (113 articles, last 24 months); acceptance rate 32% (journal website); 354 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Cancer Reports is published by Wiley and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis and Acute Lymphoblastic Leukemia research, together about 18.9% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Cancer Reports is an international, peer-reviewed, open access journal publishing basic, translational, clinical and interdisciplinary research in cancer biology, diagnosis, treatment, outcome, supportive care, epidemiology and health disparities. The journal considers data-driven, scientifically valid findings including incremental findings, pilot studies, replication and negative findings. Cancer Reports is a Wiley Open Access journal, one of a new series of peer reviewed titles publishing quality research with speed and efficiency. For more information visit the Wiley Open Access website. Article types: Original Research, Brief Report, Method Report, Clinical Study Report, Registered Report, Case Report and Review (literature and systematic). Click here for more details. Cancer Reports publishes papers submitted directly to the journal and those referred from a select group of prestigious journals published by Wiley.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Oncology
Editor-in-chief Sumit SharmaPublisher website
Editorial board by country: 2 in mainland China (about 4%); most named United States 28, India 10, Mainland China 2, Germany 2, United Kingdom 1 (48 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Immunotherapy and BiomarkersMedicine7.5%
- Ferroptosis and cancer prognosisMedicine5.9%
- Acute Lymphoblastic Leukemia researchMedicine5.5%
- Head and Neck Cancer StudiesMedicine5.4%
- Cancer survivorship and careMedicine5.1%
- Global Cancer Incidence and ScreeningMedicine5.1%
- Childhood Cancer Survivors' Quality of LifeMedicine4.6%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPMCEmbaseCASPublisher website
Other: Google Scholar, EBSCO, Dimensions
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.5Publisher website ·
- Impact factor (publisher) 2025
- 2.5Publisher website ·
- CiteScore 2026-06
- 3.7LetPub ·
- CiteScore (publisher)
- 3.7Publisher website ·
- CiteScore (publisher) 2025
- 3.7Publisher website ·
- SJR 2026-06
- 0.71LetPub ·
- SNIP 2026-06
- 0.7LetPub ·
- h-index
- 32OpenAlex ·
- i10-index
- 270OpenAlex ·
- 2-year mean citedness
- 1.58OpenAlex ·
- Self-citation rate
- 4%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 322LetPub ·
- Articles per year (publisher) 2025
- 324Publisher website ·
- Downloads per year (publisher) 2025
- 578,456Publisher website ·
Articles by year OpenAlex count · 1,766 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 242 | 242 | 39 |
| 2025 | 354 | 354 | 430 |
| 2024 | 275 | 275 | 909 |
| 2023 | 203 | 203 | 1,617 |
| 2022 | 193 | 193 | 1,145 |
| 2021 | 257 | 257 | 2,588 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
226 daysMedian, submission to acceptance · P25–P75 155 days – 287 days
- Acceptance to online
- median 17 days (113 articles)
- Submission to online
- median 255 days
- Sample
- 113 articles with submission and acceptance dates (646 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 17 weeksLetPub ·
- Acceptance rate (publisher)
- 32%Publisher website ·
- Acceptance rate (publisher) 2025
- 32%Publisher website ·
- Submission to first decision
- 67 daysPublisher website ·
- Submission to first decision 2025
- 67 daysPublisher website ·
- Submission to acceptance 2025
- 235 daysPublisher website ·
- Acceptance to publication 2025
- 18 daysPublisher website ·
- Submission to publication (journal-reported)
- about 17 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,440 / GBP 2,550 / EUR 3,130 | Yes | CC BY | |
| OpenAlex | USD 3,280 / EUR 2,980 / GBP 2,550 | — | — | |
| LetPub | USD 2,970 / GBP 2,310 / EUR 2,700 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Reference style
- Author–date
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
Article types accepted13
- brief reportCancer Reports accepts a broad range of papers which include: Original article – Original research study or meta-analysis that adds to current knowledge, offers…Length not stated
- case reportCancer Reports accepts a broad range of papers which include: Original article – Original research study or meta-analysis that adds to current knowledge, offers…Length not stated
- commentaryCancer Reports accepts a broad range of papers which include: Original article – Original research study or meta-analysis that adds to current knowledge, offers…Length not stated
- editorialCancer Reports accepts a broad range of papers which include: Original article – Original research study or meta-analysis that adds to current knowledge, offers…Length not stated
- letter to the editorCancer Reports accepts a broad range of papers which include: Original article – Original research study or meta-analysis that adds to current knowledge, offers…Length not stated
- meta-analysisCancer Reports accepts a broad range of papers which include: Original article – Original research study or meta-analysis that adds to current knowledge, offers…Length not stated
- original articleCancer Reports accepts a broad range of papers which include: Original article – Original research study or meta-analysis that adds to current knowledge, offers…Length not stated
- original researchCancer Reports accepts a broad range of papers which include: Original article – Original research study or meta-analysis that adds to current knowledge, offers…Length not stated
- perspectiveCancer Reports accepts a broad range of papers which include: Original article – Original research study or meta-analysis that adds to current knowledge, offers…Length not stated
- registered reportCancer Reports accepts a broad range of papers which include: Original article – Original research study or meta-analysis that adds to current knowledge, offers…Length not stated
- research paperCancer Reports accepts a broad range of papers which include: Original article – Original research study or meta-analysis that adds to current knowledge, offers…Length not stated
- reviewCancer Reports accepts a broad range of papers which include: Original article – Original research study or meta-analysis that adds to current knowledge, offers…Length not stated
- systematic reviewCancer Reports accepts a broad range of papers which include: Original article – Original research study or meta-analysis that adds to current knowledge, offers…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, Open access, Peer review, Preprints, Self-archiving, Trial registration / reporting guidelines
- Authorship Authorship and "CRediT" taxonomy
The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest
The journal requires that all authors disclose any potential sources of conflict of interest (CoI). Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. …
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
Cancer Reports recognizes the many benefits of archiving research data. Cancer Reports expects you to archive all the data from which your published results are derived in a public repository. The repository that you choose should offer you guaranteed preservation (see the registry of research data repositories at https://www.re3data.org/) and should help you make it findable, accessible, interope…
Source ↗Publisher website ·- Publication ethics 6. PEER REVIEW, EDITORIAL POLICIES AND PUBLICATION ETHICS
A. Manuscript Evaluation Criteria and Peer Review The acceptance criteria for all papers are scientific rigor, evidence that the data support conclusions, adherence to technical and ethical standards and the scope of the journal. Manuscripts are single-blind peer reviewed in which peer reviewer identities are kept confidential. Wiley's policy on confidentiality of the review process is available h…
Source ↗Publisher website ·- Open access 7. AUTHOR LICENSING and OPEN ACCESS FEES
Cancer Reports is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI de…
Source ↗Publisher website ·- Peer review 6. PEER REVIEW, EDITORIAL POLICIES AND PUBLICATION ETHICS
A. Manuscript Evaluation Criteria and Peer Review The acceptance criteria for all papers are scientific rigor, evidence that the data support conclusions, adherence to technical and ethical standards and the scope of the journal. Manuscripts are single-blind peer reviewed in which peer reviewer identities are kept confidential. Wiley's policy on confidentiality of the review process is available h…
Source ↗Publisher website ·- Preprints Preprints
Cancer Reports will consider submissions that have previously been made available online, either on a preprint server like arXiv, bioRxiv, or PeerJ PrePrints, or on the authors’ own website. However, any such submissions must not have been published in a scientific journal, book or other venue that could be considered formal publication. Authors must inform the editorial office at submission if th…
Source ↗Publisher website ·- Self-archiving Self-Archiving
Authors may deposit their work (whether the submitted version, accepted version, or published version) in an institutional or other repository of their choice without embargo.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectivel…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- United States
- Language
- English
- Frequency
- Monthly
- Founded
- 2018
- ISSN
- 2573-8348
- Latest issue on the website
- Volume 9, Issue 9 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cancer Reports
What CAS zone is Cancer Reports in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cancer Reports is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cancer Reports?
The journal's website gives an impact factor of 2.5 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 3.7, h-index 32.
How long does peer review take at Cancer Reports?
Based on the dates recorded on 113 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 226 days (interquartile range 155–287 days); authors report an average review time of about 17 weeks; the journal's website gives an acceptance rate of 32% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Cancer Reports?
According to the journal's author guidelines: Reference style: Author–date; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Cancer Reports based?
Of the 48 board members whose country the journal's board page names, 2 (about 4%) are in mainland China; the countries named most often are United States (28), India (10) and Mainland China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Cancer Reports?
According to LetPub and DOAJ records, Cancer Reports is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE, PMC, Embase and CAS; that list has not been checked against each database.
Is Cancer Reports open access, and what is the APC?
Cancer Reports is a fully open-access journal. APC about USD 3,440.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .